poLight ASA (DE:3OL0) has released an update.
PoLight ASA faced a slow revenue quarter but remained active by exploring market opportunities in AR/MR and machine vision sectors, while expanding its presence in healthcare research applications. Despite reporting an EBITDA loss of NOK 25.2 million, the company secured new purchase orders and confirmed its TLens® technology in new products, underlining the potential for future growth. The company ended the quarter with strong cash reserves of NOK 180.1 million, positioning itself well for ongoing and future projects.
For further insights into DE:3OL0 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
